DNA (deoxyribonucleic acid) molecule for constructing coxiella burnetii inducible CRISPRi (clustered regularly interspaced short palindromic repeats i) system and application
A technology of C. bainische and DNA molecules, applied in the field of genetic engineering, can solve the problems of cumbersome operation, low incidence of homologous recombination, and cost.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0067] Example 1. Construction of an inducible CRISPRi system
[0068] 1.1. Construction of pdCas9 plasmid
[0069] (1) dCas9 gene synthesis
[0070] GenScript Biotechnology Co., Ltd. was entrusted to artificially synthesize the dCas9 gene of Streptococcus pyogenes. The nucleotide sequence of the dCas9 gene is SEQ ID No.1, of which the 1-6th position of SEQ ID No.1 is the BglII enzyme cleavage site, Positions 7-18 are RBS, positions 25-4131 are dCas9 gene, and positions 4132-4137 are SalI restriction sites.
[0071] (2) teto-TetR sequence synthesis
[0072] Entrust GenScript Biotechnology Co., Ltd. to synthesize the tetO-TetR sequence. The nucleotide sequence of the synthesized sequence is SEQ ID No.2, of which the 1-6th position of SEQ ID No.2 is the EcoRI restriction site , the 7-630th position is the reverse complement of Tet repressor protein (TetR), the 649th-704th position is the Tet operon (Tetoperator, TetO), and the 716th-721st position is the BglII restriction sit...
Embodiment 2
[0092] Example 2. Detection of the efficiency of inducible CRISPRi system in inhibiting the expression of dotB in Kirkkiella
[0093] 2.1. Preparation of DotB and Com1 protein antiserum
[0094] (1) Preparation of Cokes body dot B gene and com 1 gene prokaryotic expression vector, dot The nucleotide sequence of the coding sequence of the B gene is SEQ ID No. 4, com The nucleotide sequence of the 1 gene is SEQ ID No.5.
[0095] (2) Insert the above sequences into the multiple cloning sites of the prokaryotic expression vector pET32a(+) respectively, and transform into E. coli BL21 (DE3) competent cells (Beijing Quanshijin Biotechnology Co., Ltd., product number CD601-02) , and then cultured in LB liquid medium at 37 °C and 200 r / min for more than 14 h. Then transfer into LB liquid medium containing ampicillin resistance at a volume ratio of 1:100, and cultivate to OD at 37 °C and 200 r / min. 600 = 0.6, then IPTG was added to make the final concentration in the system 5...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com